D

DURECT Corp
D

DRRX

0.56500
USD
0.02
(3.67%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
17,539,058
أصول ذات صلة
A
ALDX
0.13500
(5.73%)
2.49000 USD
A
AQST
0.22500
(7.06%)
3.41000 USD
A
AXSM
-1.430
(-1.30%)
108.740 USD
B
BHC
0.07500
(1.64%)
4.65500 USD
B
BNTC
0.310
(2.00%)
15.830 USD
CAH
CAH
-0.880
(-0.57%)
154.640 USD
المزيد
الأخبار المقالات

العنوان: DURECT Corp

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.